Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109–116
- 13 April 2023
- journal article
- letter
- Published by Elsevier in European Urology
- Vol. 84 (1) , e16-e17
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell CarcinomaEuropean Urology, 2023
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of CareEuropean Urology, 2021
- Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaNature Reviews Clinical Oncology, 2021
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaEuropean Urology, 2019